Delivery Order SPE2DB24D3015-SPE2DB25FFYMH
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $10,005.30. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 28, 2024. The contract was not set aside for any specific business type....
This contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The $7,553.98 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 11, 2024 with a completion date of March 12, 2024. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The $11,693.25 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on July 11, 2024 with a completion date of July 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $4,815.84, was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. This is a firm fixed-price delivery order contract with a completion date of June 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of CONTRAVE ER 8/90MG 120, a prescription pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract has a firm fixed price of $28,603.83 and a completion date of September 4, 2024. It is a delivery order contract with no set-aside designation....
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication, to the Defense Logistics Agency (DLA). The $2,386.64 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The $2,398.02 firm fixed price contract was awarded on July 2, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has an ultimate completion date of July 3, 2024. This is a delivery order contract and does not have a set-aside designation. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,848.40 and is a Firm Fixed Price Delivery Order with an ultimate completion date of January 30, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA), which is a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $1,199.01. It does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $10,425.58 and is a firm fixed-price delivery order with an ultimate completion date of September 9, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract does not have a set-aside designation....